Abstract:Objective To investigate the effect of rosmarinic acid(RA)on oxidative stress injury of H9C2 cardiomyocytes. Methods The oxidative stress injury model was established by hydrogen peroxide (H2O2) treatment. H9C2 cardiomyocytes were cultured in vitro and randomly divided into control group, H2O2 group and H2O2+RA group. The H2O2 group was treated with 400μmol/L H2O2 for 4h to establish the oxidative stress injury model;H2O2+RA group was treated with low dose(5μg/ml),medium dose(10μg/ml) and high dose(20μg/ml)of RA for 24 h before adding H2O2. CCK-8 assay was used to detect the survival rate of H9C2 cardiomyocytes;DCFH-DA probe with a microplate reader was used to measure the intracellular reactive oxygen species(ROS)content;specific kits were used to measure the amount of lactate dehydrogenase (LDH) leakage,intracellular malondialdehyde (MDA) content,and activities of catalase (CAT)and glutathione peroxidase(GSH-Px). Western blotting and real-time fluorescence quantitative PCR were used to detect the levels of reduced coenzyme II oxidase 2(NOX2),superoxide dismutase 2(SOD2) and the expression of apoptosis-related genes Bax,Bcl-2,cleavage-caspase 3(c-cas 3)and caspase 3(cas 3);TUNEL kit was used to examine the cell apoptosis. Results (1)The cell viability of all H2O2-treated group was lower than that of the control group. Lower-dose RA did not,but higher-levels RA(≥30μg/ml) significantly inhibited the growth of H9C2 cardiomyocytes.(2)Compared with the control group,the cell survival rate in the H2O2 group decreased by 52.9%,and the LDH leakage increased by 73.8%. RA pretreatment increased the cell survival rate and decreased the LDH leakage,and such protective effect increased significantly along with the RA concentration.(3)Compared with the control group,H2O2 group had significantly elevated intracellular oxidation as reflected by a 146.7% increased in MDA level and a 192.2%increase in ROS level. RA pretreatment resulted in reduced ROS production and lower intracellular MDA content,which was more obvious with higher doses of RA. (4) Compared with the control group, apoptosis in the H2O2 group was obvious. RA pretreatment could improve H2O2-induced apoptosis,and the improvement was more prominent with higher doses of RA. Conclusion RA exhibits significant protective effect on H9C2 cardiomyocytes under oxidative stress.

Rosmarinic Acid Protects Against Inflammation and Cardiomyocyte Apoptosis During Myocardial Ischemia/Reperfusion Injury by Activating Peroxisome Proliferator-Activated Receptor Gamma

Cardioprotective effect of rosmarinic acid against myocardial ischaemia/reperfusion injury via suppression of the NF-κB inflammatory signalling pathway and ROS production in mice

MiR-30c-5p Mediates the Effects of Panax Notoginseng Saponins in Myocardial Ischemia Reperfusion Injury by Inhibiting Oxidative Stress-Induced Cell Damage.

Effects of Peroxisome Proliferator-Activated Receptor Γ Activator Rosiglitazone on Myocardial Ischemic-Reperfusion Injury in Rats

Cardioprotective effects of acute rosiglitazone treatment

Rosmarinic Acid Attenuates Cardiac Fibrosis Following Long-Term Pressure Overload Via AMPKα/Smad3 Signaling.

Rosa Rugosa Flavonoids Alleviate Myocardial Ischemia Reperfusion Injury in Mice by Suppressing JNK and P38 MAPK

Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway

Rosmarinic acid attenuates TNF-α induced cardiomyocyte injury via regulating miR-344a-3p

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity

Effects of rosmarinic acid on myocardial calcium transport and cardiac function in ischemic rats

Influence of Rosiglitazone on the Ventricular Haemodynamics,Histological Change,and Apoptosis Level of Cardiomyocytes in Rat's Myocardial Infarction Models

Experimental Study on Rosiglitazone Reversing Myocardial Interstitial Fibrosis of Rats with Heart Failure

Protective Effect of Rosiglitazone on Myocardial Ischemia-Reperfusion Injury in Rats

Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction.

[PPAR Gamma Agonist Rosiglitazone Alleviates Hypoxia/reoxygenation-Induced Oxidative Stress and Apoptosis in Rat Cardiac Myocytes].

The protective effect of polyphyllin I on myocardial ischemia/reperfusion injury in rats

Effects of Rosmarinic Acid on Oxidative Stress Injury of H9C2 Cardiomyocytes

Asiatic Acid Alleviates Myocardial Ischemia-Reperfusion Injury by Inhibiting the ROS-Mediated Mitochondria-Dependent Apoptosis Pathway

Rosiglitazone Inhibits Hypercholesterolaemia-Induced Myeloperoxidase Upregulation--a Novel Mechanism for the Cardioprotective Effects of PPAR Agonists.

Neuroprotection against focal ischemic brain injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.